SKB264 Innovative Cancer Antibody Drug Conjugate Clinical Trials Efficacy Insight
September 19, 2024 07:34 ET
|
KuicK Research
Delhi, Sept. 19, 2024 (GLOBE NEWSWIRE) -- SKB264, also known as MK-2870, is an innovative antibody-drug conjugate (ADC) targeting TROP2, currently being developed by Kelun Biotech in partnership...
Comstock Fuels Executes International License Agreement
September 18, 2024 11:10 ET
|
Comstock Inc.
VIRGINIA CITY, Nev., Sept. 18, 2024 (GLOBE NEWSWIRE) -- Comstock Inc. (NYSE: LODE) (“Comstock” and the “Company”) today announced execution of a binding agreement between Comstock Fuels Corporation...
Bispecific Antibody Drug Conjugates Clinical Trials Insight
September 17, 2024 07:14 ET
|
KuicK Research
Delhi, Sept. 17, 2024 (GLOBE NEWSWIRE) -- The global market for bispecific antibody-drug conjugates (BsADCs) has experienced remarkable expansion, attributed to their revolutionary capabilities in...
Adeia and LG Electronics Renew Media IP License Agreement
September 16, 2024 07:18 ET
|
Adeia Inc.
SAN JOSE, Calif., Sept. 16, 2024 (GLOBE NEWSWIRE) -- Adeia Inc. (Nasdaq: ADEA), a leading technology company bringing technology from incubation to reality, today announced the renewal of its...
PodcastOne (Nasdaq: PODC) Acquires Exclusive Multi-Year Sales and Distribution Rights to Fool Coverage with Manny MUA and Laura Lee Podcast
September 13, 2024 08:00 ET
|
PodcastOne
Fool Coverage Has 153 Episodes Since Its Launch in 2021 17th New Podcast Joining PodcastOne Network This Fiscal Year, 45th in Last 12 Months 3.8 Billion All-Time Network Downloads LOS...
Bispecific Antibody Drug Conjugates Clinical Trials FDA Approval Commercial Launch Market Forecast 2029
September 12, 2024 07:49 ET
|
KuicK Research
Delhi, Sept. 12, 2024 (GLOBE NEWSWIRE) -- Global Bispecific Antibody Drug Conjugates Clinical Trials, Regulatory Approvals & Future Market Opportunity Outlook 2029 Report: Report Answers...
Arteris Interconnect IP Selected by VeriSilicon for High-Performance SoC Design
September 10, 2024 09:00 ET
|
Arteris, Inc.
CAMPBELL, Calif., Sept. 10, 2024 (GLOBE NEWSWIRE) -- Arteris, Inc. (Nasdaq: AIP), a leading provider of system IP which accelerates system-on-chip (SoC) creation, today announced that VeriSilicon...
Tenstorrent와 Movellus, 차세대 칩렛 기반의 AI 및 HPC 솔루션 발전 위한 전략적 파트너십 체결
September 09, 2024 22:29 ET
|
Movellus
양사 협력 통해 전력 및 성능 최적화를 위한 크로스 파운드리 IP 활성화 전망 서니베일, 캘리포니아, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Movellus와 Tenstorrent가 전략적 제휴의 일환으로 Tenstorrent의 AI 및 HPC 칩렛 솔루션 부문에 Movellus의 디지털 IP 제품군 사용이 가능한 라이선스를...
Tenstorrent 和 Movellus 建立戰略合作關係，推動新一代小晶片為主的 AI 和高效能運算解決方案
September 09, 2024 22:29 ET
|
Movellus
加州桑尼維爾, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Movellus 和 Tenstorrent 宣布，Tenstorrent 已經授權 Movellus 的數碼 IP 系列，作為其 AI 和高效能運算小晶片解決方案戰略合作的一部分。 是次合作旨在充分發揮兩家公司的優勢，開發小晶片為主的解決方案，以提升性能並優化功率。 Movellus Aeonic...
Tenstorrent 与 Movellus 达成战略合作，共同开发下一代基于芯粒的 AI 和 HPC 解决方案
September 09, 2024 22:29 ET
|
Movellus
加州森尼维尔, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Movellus 和 Tenstorrent 宣布，作为战略合作的一部分，Tenstorrent 已获得 Movellus 数字 IP 系列的授权，用于其 AI 和 HPC 解决方案。 此次合作旨在利用双方公司的优势，开发基于芯粒的解决方案，以在优化功耗的同时增强性能。 Movellus Aeonic 数字...